-12.70(-0.98%)

-0.25(-1.62%)

+0.0005(+0.0455%)

Tilray, Inc. Is Poised to Cash in on the Cannabis Potential, Analysts Review and Target

NEW YORK, NY / ACCESSWIRE / January7, 2019 / Traders News Source, a leading independent equity researchand corporate access firm focused on small and mid-cap public companies isissuing a comprehensive report on Tilray, Inc. (NASDAQ: TLRY), a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents.

In the recent past, the company's stock has shown an uptrend, led by its strong fundamentals and multiple positive catalysts/development's in the recent past. It is one of those few companies which is well-positioned in both medical and recreational use cannabis sector.

Building its brand and supply chain has become the company's core focus, and it has built a premium, vertically-integrated business to pioneer the development of multiple markets around the globe. While this approach will continue to require initial investments in the short-term, the same is expected to create a strong foundation and unique barriers to entry that can be leveraged and scaled in the medium to long-term.

Readabout the company's recent growth initiatives, Q3 financials and much more READ MORE

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.